MedTrace Logo

The RECORD Asia-Pacific Atrial Fibrillation Registry

NCT00995748 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2674

Last updated 2012-02-20

No results posted yet for this study

Summary

The Primary objective of this registry is to assess the control of Atrial Fibrillation (AF) over one year in patients attending clinical or specialized practices.

The Secondary objectives are:

* To describe key demographics and treatment features in AF patients visiting cardiologists in various countries in Asia-Pacific.
* To establish correlation between control of AF and clinical outcomes.
* To establish correlation between treatment strategies and AF control.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Clinical Sciences & Operations · Sanofi

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • Australia
  • China
  • Hong Kong
  • Malaysia
  • Philippines
  • South Korea
  • Taiwan
  • Thailand

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00995748 on ClinicalTrials.gov